McGuire Investment Group LLC Increases Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

McGuire Investment Group LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,440 shares of the medical equipment provider’s stock after purchasing an additional 46 shares during the quarter. Intuitive Surgical comprises approximately 1.8% of McGuire Investment Group LLC’s portfolio, making the stock its 20th biggest position. McGuire Investment Group LLC’s holdings in Intuitive Surgical were worth $12,235,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth $558,807,000. International Assets Investment Management LLC raised its position in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after acquiring an additional 1,088,415 shares in the last quarter. FMR LLC lifted its stake in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB boosted its stake in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Finally, State Street Corp grew its holdings in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 42,475 shares of company stock valued at $22,070,807 over the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $584.05 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm’s 50-day moving average is $546.03 and its 200-day moving average is $503.38. The company has a market cap of $208.03 billion, a P/E ratio of 93.90, a PEG ratio of 5.19 and a beta of 1.39.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Piper Sandler reiterated an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday. Royal Bank of Canada increased their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Finally, Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $583.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.